Gufic BioSciences' Q1 FY 2025-26 Quarterly Results
- 14 Aug 2025
Result Summary
- Gufic BioSciences Ltd reported a 14.7% quarter-on-quarter (QoQ) increase in its consolidated revenues for the quarter-ended Jun (Q1 FY 2025-26). On a year-on-year (YoY) basis, it witnessed a growth of 10.1%.
- Its expenses for the quarter were up by 22.9% QoQ and 17.9% YoY.
- The net profit decreased 34.8% QoQ and decreased 37.3% YoY.
- The earnings per share (EPS) of Gufic BioSciences Ltd stood at 1.3 during Q1 FY 2025-26.
Financial Statments for Q1 FY 2025-26
| (₹ crores) | Q1FY26 | Q4FY25 | Q1FY25 | QoQ (%) | YoY (%) |
|---|---|---|---|---|---|
Total Income | 224.65 | 195.87 | 204.07 | 14.7% | 10.1% |
Total Expenses | 207.37 | 168.76 | 175.96 | 22.9% | 17.9% |
Profit Before Tax | 17.27 | 27.12 | 28.10 | -36.3% | -38.5% |
Tax | 4.20 | 7.07 | 7.25 | -40.6% | -42.1% |
Profit After Tax | 13.07 | 20.05 | 20.86 | -34.8% | -37.3% |
Earnings Per Share | 1.30 | 2.00 | 2.10 | -35.0% | -38.1% |
Data Source: BSE, Company announcements The securities quoted are exemplary and are not recommendatory. Past performance is not indicative of future results
Company Overview
Gufic BioSciences Ltd is a pharmaceutical company engaged in the development and production of a wide range of pharmaceutical formulations, injectable medications, and herbal products. The company operates primarily in the pharmaceutical industry, providing essential healthcare products and services. Gufic BioSciences is known for its focus on innovation and quality in the healthcare sector. Recent major developments for the company include advancements in their manufacturing capabilities and expansion of their product portfolio, although specific details related to these developments are not available in the provided data.
Revenue
In the first quarter of fiscal year 2026 (Q1FY26), Gufic BioSciences Ltd reported a total income of ₹224.65 crores. This represents a quarter-over-quarter (QoQ) increase of 14.7% compared to the ₹195.87 crores recorded in the fourth quarter of fiscal year 2025 (Q4FY25). Year-over-year (YoY), the total income increased by 10.1% from ₹204.07 crores in the first quarter of fiscal year 2025 (Q1FY25). The growth in revenue indicates an upward trend in the company's total income over both the quarterly and yearly periods.
Profitability
In Q1FY26, Gufic BioSciences Ltd's profit before tax was ₹17.27 crores, which is a decline of 36.3% QoQ from ₹27.12 crores in Q4FY25. Compared to Q1FY25, there was a YoY decrease of 38.5% from ₹28.10 crores. The company's tax expenses for Q1FY26 were ₹4.20 crores, decreasing by 40.6% QoQ from ₹7.07 crores and by 42.1% YoY from ₹7.25 crores. Profit after tax for Q1FY26 stood at ₹13.07 crores, a decline of 34.8% QoQ from ₹20.05 crores in Q4FY25 and a YoY decrease of 37.3% from ₹20.86 crores in Q1FY25. Earnings per share (EPS) in Q1FY26 was ₹1.30, down 35.0% QoQ from ₹2.00 and down 38.1% YoY from ₹2.10.
Operating Metrics
The total expenses for Gufic BioSciences Ltd in Q1FY26 were ₹207.37 crores, which represents an increase of 22.9% QoQ from ₹168.76 crores in Q4FY25 and a YoY increase of 17.9% from ₹175.96 crores in Q1FY25. The increase in expenses outpaced the growth in total income for the quarter, impacting the company's profitability. Key financial ratios, such as the P/E ratio and debt-to-equity ratio, are not provided in the data, preventing a detailed analysis of these metrics. However, the increase in expenses relative to income is a significant trend observed in the financial performance for the quarter.
FAQs
When was Gufic BioSciences Ltd Q1 FY 2025-26 result announced?
Gufic BioSciences Ltd announced its Q1 FY 2025-26 results on 14 August, 2025.
What are Gufic BioSciences Ltd quarterly results?
Gufic BioSciences Ltd quarterly results refer to the company’s financial performance over a three-month period, including key metrics like revenue, net profit, earnings per share (EPS), and margin performance.
What were the key highlights of Gufic BioSciences Ltd Q1 FY 2025-26 results?
Key highlights of Gufic BioSciences Ltd Q1 FY 2025-26 results include:
- Revenue: ₹224.65 crore
- Net Profit: ₹13.07 crore
- EBITDA: ₹34.23 crore
- Year-over-Year Growth: 10.1%
- Quarter-over-Quarter Growth: 14.7%
How did Gufic BioSciences Ltd net profit perform in this quarter?
Gufic BioSciences Ltd reported a net loss of ₹13.07 crore in Q1 FY 2025-26, reflecting a -37.3% year-over-year growth.
What was Gufic BioSciences Ltd revenue in Q1 FY 2025-26?
Gufic BioSciences Ltd posted a revenue of ₹224.65 crore in Q1 FY 2025-26.